EUVIMEDEUVIMED entdecken
Crossref

Epigenetically inhibiting CYP3A5 modulates the migration and invasion of esophageal squamous cell carcinoma

Xintong Jiang, Yanhong Wang, Jun Ouyang, Jinkai Zhao, Su Zeng, Xiaoli Zheng, Lushan Yu

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Xintong Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Epigenesis, Genetic. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3AEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsEpigenesis, GeneticCell MovementHumansCell Line, TumorNeoplasm InvasivenessAnimalsMiceGene Expression Regulation, NeoplasticMalePromoter Regions, GeneticAcetylationFemaleMice, NudeHistone Deacetylase InhibitorsDown-RegulationHydroxamic AcidsMice, Inbred BALB CHistones

Stichwörter der Autor:innen

CYP3A5Esophageal squamous cell carcinomaHistone acetylationMetastasis

Substanzen

Cytochrome P-450 CYP3ACYP3A5 protein, humantrichostatin AHistone Deacetylase InhibitorsHydroxamic AcidsHistones

Autor:innen und Institutionen

  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China.
  • Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, China.
  • Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, China. Electronic address: zhengxl@hzcu.edu.cn.
  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Electronic address: yuls@zju.edu.cn.

Förderung

  • Science and Technology Department of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, X., Wang, Y., Ouyang, J., Zhao, J., Zeng, S., Zheng, X., & Yu, L. (2025). Epigenetically inhibiting CYP3A5 modulates the migration and invasion of esophageal squamous cell carcinoma. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100201

Vancouver

Jiang X, Wang Y, Ouyang J, Zhao J, Zeng S, Zheng X, et al. Epigenetically inhibiting CYP3A5 modulates the migration and invasion of esophageal squamous cell carcinoma. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100201

BibTeX
@article{Jiang2025,
  author = {Jiang, Xintong and Wang, Yanhong and Ouyang, Jun and Zhao, Jinkai and Zeng, Su and Zheng, Xiaoli and Yu, Lushan},
  title = {Epigenetically inhibiting CYP3A5 modulates the migration and invasion of esophageal squamous cell carcinoma},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100201}
}
Kostenlos starten →